Back
AbCellera Biologics Vs. InMed Pharmaceuticals Industry Stock Comparison
Sell
35
ABCL
AbCellera Biologics
Last Price:
3.76
Seasonality Move:
-3.7%
Sell
11
INM
InMed Pharmaceuticals
Last Price:
0.23
Seasonality Move:
-31.59%
Sell
35
AbCellera Biologics (ABCL)
is a Sell
Is AbCellera Biologics a Buy, Sell or Hold?
- The current AbCellera Biologics [ABCL] share price is $3.76. The Score for ABCL is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- ABCL is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
11
InMed Pharmaceuticals (INM)
is a Sell
Is InMed Pharmaceuticals a Buy, Sell or Hold?
- The current InMed Pharmaceuticals [INM] share price is $0.23. The Score for INM is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.
- INM is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
ABCL Stock Price Chart
What is AbCellera Biologics's stock price today?
-
The AbCellera Biologics share price today is $3.76
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABCL is experiencing slight buying pressure.
INM Stock Price Chart
What is InMed Pharmaceuticals's stock price today?
-
The InMed Pharmaceuticals share price today is $0.23
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INM is experiencing selling pressure, which indicates risk of future bearish movement.
ABCL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.23 | Sell |
Relative Strength Index (14 RSI): | 34.23 | Sell |
Chaikin Money Flow: | 682276 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.95 - 4.53) | Sell |
Bollinger Bands (100): | (4.41 - 5.49) | Sell |
INM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.03 | Sell |
Relative Strength Index (14 RSI): | 29.26 | Sell |
Chaikin Money Flow: | -367190 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.28 - 0.36) | Sell |
Bollinger Bands (100): | (0.32 - 0.4) | Sell |
ABCL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.88 | Sell |
20-day SMA: | 4.18 | Sell |
50-day SMA: | 4.58 | Sell |
200-day SMA: | 5.12 | Sell |
8-day EMA: | 3.89 | Sell |
20-day EMA: | 4.13 | Sell |
50-day EMA: | 4.47 | Sell |
200-day EMA: | 5.37 | Sell |
INM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.28 | Sell |
20-day SMA: | 0.32 | Sell |
50-day SMA: | 0.35 | Sell |
200-day SMA: | 0.55 | Sell |
8-day EMA: | 0.28 | Sell |
20-day EMA: | 0.31 | Sell |
50-day EMA: | 0.34 | Sell |
200-day EMA: | 0.97 | Sell |
AbCellera Biologics Earnings Growth & ABCL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.03 per share, a decrease this year of $0.18 per share, and a decrease next year of $0.05 per share.
InMed Pharmaceuticals Earnings Growth & INM Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
AbCellera Biologics Technical Analysis
Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
InMed Pharmaceuticals Technical Analysis
Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |